FDA advisory board expected to discuss Pfizer’s Covid vaccine for kids

The FDA advisory board will meet Tuesday to discuss emergency approval for Pfizer’s Covid-19 vaccine for children ages 5 to 11. This comes as Moderna just announced its vaccine for children triggers a “robust” immune response with mostly mild to moderate side effects.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting